Table 2.
Statistical analysis of the mean BNMN and MNf of healthy controls and (A) mCRC/laRC patients at the beginning (before).
| Groups | BN cells scored | Mean ± SE | G | P | |
|---|---|---|---|---|---|
| BNMN | Control | 25,000 | 7.28 ± 1.06 | ||
| mCRC Before | 55,000 | 29.3 ± 9.07 | 38.00 | <0.001 | |
| laRC Before | 21,000 | 26.4 ± 4.82 | 30.15 | <0.001 | |
| MN cells | Control | 25,000 | 8.18 ± 1.11 | ||
| mCRC Before | 55,000 | 32.3 ± 9.97 | 41,1 | <0.001 | |
| laRC Before | 21,000 | 29.6 ± 5.21 | 33,76 | <0.001 | |
|
CBPI ± SE
(Mean ± SE) |
Control | 1.29 ± 0.03 | |||
| mCRC Before | 1.32 ± 0.004 | ||||
| laRC Before | 1.36 ± 0.007 |
Values in bold font indicate statistically significant differences (P < 0.05) compared with the controls. G indicates 2POi ln(Oi/Ei), where ‘Oi’ is the observed frequency in a cell, ‘Ei’ is the expected frequency under the null hypothesis, ‘ln’ denotes the natural logarithm and the sum is taken over all non-empty cells. SE, standard error; BN, binucleated cells (for each patient 1,000 BN cells were scored); BNMN, binucleated cells with micronuclei.